Dr Martens reaffirms full-year guidance as 'strong' retail recovery continues
"The early months of our financial year are typically the smallest period of the year, representing the tail end of the spring/summer trading period"
Archive
2397 stories · page 44 of 120
"The early months of our financial year are typically the smallest period of the year, representing the tail end of the spring/summer trading period"
KEFI has an extensive portfolio of assets in Saudi Arabia and Ethiopia
The struggling British fashion chain said it had net debt of £21.4mln at end-May, giving £11.3mln headroom within its banking facilities
“The acquisition of Texon will strengthen our existing presence in the highly attractive athleisure footwear market," said Coats chief executive Rajiv Sharma
The UK business owns rival Vuse, which is in a prime position to pick up business from Juul customers
The group's chief executive warned of the cost-of-living pressures facing customers and increased costs in its supply chain
Sales will exceed £24mln in the first half of this year, a record for the group and ahead of expectations at the start of the year
The broker notes that the denial/ban is based on insufficient toxicological evidence
BAT especially benefits further from strong NGP (next generation) momentum
A quiet day in London in the diary and on the streets with another rail strike planned
Research showed more than half of adult cigarette smokers make a serious quit attempt each year, but most do not succeed due to the addictive nature of nicotine
The company, known for its nail polish and lipstick, filed for Chapter 11 to manage debts of between US$1bn to US$10bn
Britain's blue-chip benchmark finished down over 116 points, or 1.54%, at 7,476 on the day
Will the ECB join the central bank rush to hike interest rates?
Will traditional defensive sectors provide the same protection or will things be different?
The group's two largest regions, Americas and Europe, Middle East and Africa saw revenue gains of 29% and 19% respectively, while Asia-Pacific was down 10%
Sales growth in China and America will be eyed after weak performances in the third quarter
Results at the US' largest specialty apparel company were pressured by a "slowed demand stemming from inflationary pressures impacting the lower-income consumer"
"Their extensive and diversified experience will be invaluable to our continued growth and success as we advance the development of important new anti-fibrotic and anti-inflammatory therapeutics for the treatment of heart disease," said Dr
In the three months to end-March, the company, which develops plasma processes to reduce greenhouse gases (GHG), posted revenue of C$4.2 million, down 33% compared to the first quarter of 2021